Lisanti Capital Growth, LLC - Q2 2016 holdings

$66.3 Million is the total value of Lisanti Capital Growth, LLC's 91 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 314.3% .

 Value Shares↓ Weighting
DY BuyDYCOM INDS INC$1,595,000
+242.3%
17,767
+146.7%
2.41%
+335.9%
GIMO BuyGIGAMON INC$1,416,000
+60.4%
37,870
+33.0%
2.14%
+104.2%
ASTE BuyASTEC INDS INC$1,407,000
+67.7%
25,060
+39.3%
2.12%
+113.5%
BERY NewBERRY PLASTICS GROUP INC$1,249,00032,155
+100.0%
1.88%
PVTB BuyPRIVATEBANCORP INC$1,226,000
+35.2%
27,840
+18.5%
1.85%
+72.0%
MTN BuyVAIL RESORTS INC$1,216,000
+183.4%
8,795
+174.4%
1.83%
+261.0%
MWA NewMUELLER WTR PRODS INC$1,193,000104,500
+100.0%
1.80%
WAGE NewWAGEWORKS INC$1,134,00018,965
+100.0%
1.71%
BKFS NewBLACK KNIGHT FINL SVCS INCcl a$1,113,00029,605
+100.0%
1.68%
POOL BuyPOOL CORPORATION$1,016,000
+20.1%
10,805
+12.0%
1.53%
+52.9%
SITE NewSITEONE LANDSCAPE SUPPLY INC$993,00029,215
+100.0%
1.50%
SIMO NewSILICON MOTION TECHNOLOGY COsponsored adr$970,00020,300
+100.0%
1.46%
X NewUNITED STATES STL CORP NEW$950,00056,365
+100.0%
1.43%
OFIX BuyORTHOFIX INTL N V$926,000
+128.1%
21,830
+123.4%
1.40%
+190.4%
TREX NewTREX CO INC$893,00019,890
+100.0%
1.35%
MASI NewMASIMO CORP$891,00016,970
+100.0%
1.34%
JACK NewJACK IN THE BOX INC$873,00010,155
+100.0%
1.32%
ELGX NewENDOLOGIX INC$846,00067,925
+100.0%
1.28%
INGN BuyINOGEN INC$841,000
+27.6%
16,787
+14.6%
1.27%
+62.4%
PGND NewPRESS GANEY HLDGS INC$841,00021,380
+100.0%
1.27%
ELLI BuyELLIE MAE INC$812,000
+20.3%
8,860
+19.0%
1.22%
+53.1%
NUVA NewNUVASIVE INC$791,00013,250
+100.0%
1.19%
OMCL NewOMNICELL INC$761,00022,240
+100.0%
1.15%
SUPN NewSUPERNUS PHARMACEUTICALS INC$757,00037,170
+100.0%
1.14%
FIVE NewFIVE BELOW INC$755,00016,265
+100.0%
1.14%
CONE NewCYRUSONE INC$749,00013,450
+100.0%
1.13%
NVRO NewNEVRO CORP$735,0009,960
+100.0%
1.11%
HMSY BuyHMS HLDGS CORP$715,000
+74.0%
40,630
+41.7%
1.08%
+121.4%
TWOU New2U INC$710,00024,135
+100.0%
1.07%
COR NewCORESITE RLTY CORP$697,0007,860
+100.0%
1.05%
WLH NewLYON WILLIAM HOMEScl a new$681,00042,240
+100.0%
1.03%
DOC NewPHYSICIANS RLTY TR$678,00032,280
+100.0%
1.02%
WBMD NewWEBMD HEALTH CORP$628,00010,810
+100.0%
0.95%
PRAH NewPRA HEALTH SCIENCES INC$591,00014,150
+100.0%
0.89%
WAL NewWESTERN ALLIANCE BANCORP$581,00017,785
+100.0%
0.88%
ADPTQ BuyADEPTUS HEALTH INCcl a$557,000
-6.1%
10,790
+1.1%
0.84%
+19.5%
MKSI NewMKS INSTRUMENT INC$542,00012,585
+100.0%
0.82%
CY NewCYPRESS SEMICONDUCTOR CORP$515,00048,810
+100.0%
0.78%
PE NewPARSLEY ENERGY INCcl a$511,00018,870
+100.0%
0.77%
ABMD BuyABIOMED INC$511,000
+97.3%
4,675
+71.2%
0.77%
+151.1%
ZEN NewZENDESK INC$509,00019,290
+100.0%
0.77%
AEIS NewADVANCED ENERGY INDS$505,00013,305
+100.0%
0.76%
RDUS NewRADIUS HEALTH INC$477,00012,985
+100.0%
0.72%
ITCI NewINTRA CELLULAR THERAPIES INC$476,00012,260
+100.0%
0.72%
CSII NewCARDIOVASCULAR SYS INC DEL$472,00025,685
+100.0%
0.71%
MANH BuyMANHATTAN ASSOCS INC$459,000
+14.8%
7,160
+1.8%
0.69%
+46.0%
DERM NewDERMIRA INC$453,00015,480
+100.0%
0.68%
GKOS NewGLAUKOS CORP$452,00015,490
+100.0%
0.68%
GWRE NewGUIDEWIRE SOFTWARE INC$423,0006,845
+100.0%
0.64%
ARIA NewARIAD PHARMACEUTICALS INC$421,00057,015
+100.0%
0.64%
VEEV NewVEEVA SYS INC$404,00011,830
+100.0%
0.61%
VRNS NewVARONIS SYS INC$364,00015,140
+100.0%
0.55%
KRA NewKRATON PERFORMANCE POLYMERS$352,00012,600
+100.0%
0.53%
HUBS BuyHUBSPOT INC$345,000
+19.4%
7,945
+20.1%
0.52%
+52.0%
ACIA NewACACIA COMMUNICATIONS INC$329,0008,245
+100.0%
0.50%
DOOR NewMASONITE INTL CORP NEW$313,0004,725
+100.0%
0.47%
MXL NewMAXLINEAR INCcl a$300,00016,705
+100.0%
0.45%
DEPO NewDEPOMED INC$257,00013,110
+100.0%
0.39%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-05
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MONOLITHIC PWR SYS INC33Q3 20222.0%
Q2 HLDGS INC31Q2 20242.1%
KINSALE CAP GROUP INC27Q1 20242.7%
BOOT BARN HLDGS INC27Q2 20243.1%
HUBSPOT INC27Q1 20221.6%
PENUMBRA INC27Q2 20231.8%
PLANET FITNESS INC26Q4 20232.7%
REPLIGEN CORP26Q1 20242.7%
PACIRA PHARMACEUTICALS INC25Q2 20242.6%
NEUROCRINE BIOSCIENCES INC25Q2 20241.5%

View Lisanti Capital Growth, LLC's complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-01
13F-HR2024-05-07
13F-HR2024-02-06
13F-HR2023-11-03
13F-HR2023-08-11
13F-HR2023-05-08
13F-HR2023-02-06
13F-HR2022-11-02
13F-HR2022-08-03

View Lisanti Capital Growth, LLC's complete filings history.

Compare quarters

Export Lisanti Capital Growth, LLC's holdings